Global Combination Products Market 2022

March 2022 | 17 pages | ID: GB8476F66F8DEN
StrategyHelix Inc

Abstracts

Combination products include therapeutic or diagnostic products that combine a drug or biologic with a drug delivery device. According to a report by StrategyHelix, the global combination products market is set to increase by US$ 45,602 million during 2022-2028, growing at a CAGR of 6.8% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for combination products. The global combination products market is segmented on the basis of product, application, and region. On the basis of product, the global combination products market has been segmented into drug/biologic-device combination products, drug-biologic combination products, drug-device-biologic combination products. By application, the global combination products market has been segmented into cardiovascular, diabetes, cancer treatment, respiratory diseases, others. Geographically, the global combination products market is segmented into North America, Asia Pacific, Europe, Middle East and Africa, Latin America.

The global combination products market is highly competitive. The report also includes the profiles of leading companies such as Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co. Ltd., Enable Injections Inc., Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, The 3M Company, Ypsomed AG.

Report Scope
Product: drug/biologic-device combination products, drug-biologic combination products, drug-device-biologic combination products
Application: cardiovascular, diabetes, cancer treatment, respiratory diseases, others
Region: North America, Asia Pacific, Europe, Middle East and Africa, Latin America
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders
Get a comprehensive picture of the global combination products market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. COMBINATION PRODUCTS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

Drug/biologic-device combination products
Drug-biologic combination products
Drug-device-biologic combination products

PART 4. MARKET BREAKDOWN BY APPLICATION

Cardiovascular
Diabetes
Cancer treatment
Respiratory diseases
Others

PART 5. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Middle East and Africa
Latin America

PART 6. KEY COMPANIES

Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corporation
Cipla Limited
CosMED Pharmaceutical Co., Ltd.
Enable Injections, Inc.
Johnson & Johnson
Medtronic plc
Novo Nordisk A/S
Sanofi S.A.
Smith & Nephew plc
Stryker Corporation
Terumo Corporation
The 3M Company
Ypsomed AG
About StrategyHelix
Disclaimer